Mitral Valve Prolapse, Arrhythmias & Mitral Valve Surgery

Status Recruiting

Clinical Trial Summary

Mitral valve prolapse (MVP) is associated with malignant ventricular arrhythmias (VA) and sudden cardiac death. A proper electrophysiological and echocardiographic characterization of this population is missing. Moreover, the effects of mitral valve repair on the arrhythmic burden are still matter of debate. The investigators sought to explore the role of the arrhythmic substrate in the risk stratification of patients with MVP and to assess whether mitral surgery is followed by a significant modification of the baseline arrhythmic pattern.

Clinical Trial Description

This is a prospective observational study, enrolling 200 patients with MVP and any documented VA. Diagnosis of VA obtained by 12 leads ECG and Holter recordings will be reported, as well as preprocedural premature ventricular contractions (PVC) burden assessed by 24-hour Holter monitoring; demographic and clinical data will be collected, including symptoms, documentation of VA and atrial fibrillation (AF). Echocardiography data will be analyzed, focusing on mitral regurgitation grading and mitral valve morphology analysis, assessment of leaflet redundancy and prolapse, chordal elongation, annular dilatation, presence of calcifications and mitral annular disjunction characterization. Patients will undergo ECG Holter monitoring before Cardiac Surgery with the aim to identify any VA and estimate PVC burden. ECG Holter monitoring will be repeated at 3, 9, and 12 months after cardiac surgery. In case of intraoperative biopsy, the result of histopathological examination will be collected. For patients undergoing cardiac imaging, including Cardiac Magnetic Resonance or Computer Tomography, data regarding cardiac volumes, function, markers of fibrosis will be collected. In patients undergoing Programmed electrical stimulation (PES) and Electroanatomical Mapping (EAM), size of bipolar and unipolar endocardial abnormal voltage areas, Late Potentials (LP) area, results of programmed electrical stimulation, will be evaluated. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05562804
Study type	Observational [Patient Registry]
Source	Ospedale San Raffaele
Contact	Guido Ascione, MD
Phone	0226437102
Email	ascione.guido@hsr.it
Status	Recruiting
Phase
Start date	February 10, 2021
Completion date	February 10, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05067114` - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed	`NCT02241252` - Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients	N/A
Completed	`NCT01428778` - Berlin Beat of Running Study	N/A
Completed	`NCT01626261` - Examination of Implant´s Safety in an Electronic and Magnetic Field Environment
Withdrawn	`NCT01359683` - Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias	N/A
Recruiting	`NCT04154982` - N-Acetylcysteine Protection Against Radiation Induced Cellular Damage	Phase 2
Completed	`NCT04609683` - Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure	N/A
Completed	`NCT04162249` - High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study.
Withdrawn	`NCT05084391` - Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)	Phase 1/Phase 2
Completed	`NCT03260244` - EnSite Precision Observational Study
Recruiting	`NCT04474418` - Psychometric Characterization of Patients With Cardiac Arrhythmias
Recruiting	`NCT03996954` - Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias	N/A
Recruiting	`NCT05508880` - SIGIL: Signal Interpretation and Analysis In Real Life Cardiac Arrhythmias
Terminated	`NCT04552665` - Prospective Procedural Data Collection for Continuous Improvement of the KODEX - EPD™ System Performance.
Recruiting	`NCT06073509` - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Completed	`NCT04463524` - Screening for Hearth Rhythm Disorders
Withdrawn	`NCT01394965` - Electrocardiographic Mapping and Imaging	Phase 0
Completed	`NCT01672528` - Patient Reported Outcome Measures for Ablation of Cardiac Arrhythmias
Completed	`NCT02232204` - Sleep and Ventricular Arrhythmias Study	Phase 2
Completed	`NCT05114382` - An Evaluation of the Safety and Performance of the CathVision Cube® System	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery — MVP-A&S

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms